scispace - formally typeset
P

Pingping Yan

Researcher at Centers for Disease Control and Prevention

Publications -  9
Citations -  74

Pingping Yan is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Virus & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 5, co-authored 9 publications receiving 60 citations. Previous affiliations of Pingping Yan include Fujian Medical University.

Papers
More filters
Journal ArticleDOI

Shift in HIV/AIDS Epidemic in Southeastern China: A Longitudinal Study from 1987 to 2015

TL;DR: An increasing trend is still observed in the HIV/AIDS epidemics in Fujian Province, southeastern China, and effective control interventions targeting the shift in the epidemiological features of HIV/ AIDS should therefore be implemented to control the spread of the epidemic.
Journal ArticleDOI

Epidemiological profile and risk factors of HIV and HBV/HCV co-infection in Fujian Province, southeastern China

TL;DR: Hepatitis virus screening should be included in monitoring of HIV infection, and HIV and hepatitis virus co‐infection should be considered during the development of HIV antiretroviral therapy scheme.
Journal ArticleDOI

Prevalence of HIV Indeterminate Western Blot Tests and Follow-up of HIV Antibody Sero-Conversion in Southeastern China

TL;DR: The results indicate a lower proportion of HIV indeterminate WB results in southeastern China compared to previous reports, and the follow-up re-examination of patients with HIV ind determinate results should be performed.
Journal ArticleDOI

Molecular epidemiology of hepatitis C virus among different groups of people in the province of Fujian, China

TL;DR: The differences in the main prevalent subtype between the three target groups suggest diversity of HCV prevalence in different populations.
Journal ArticleDOI

Effectiveness of first-line antiretroviral therapy in HIV/AIDS patients: A 5-year longitudinal evaluation in Fujian Province, Southeast China.

TL;DR: Long-term antiretroviral therapy remains effective for treatment of HIV/AIDS, resulting in higher mean body weight, effective viral inhibition and a higher CD4 count and a positive correlation between immunological effectiveness and viral inhibition.